Search Results - "송홍석"
-
1
Targeted therapy of ovarian cancer including immune check point inhibitor
Published in The Korean journal of internal medicine (01-09-2017)“…Epithelial ovarian cancer is the eighth most common cause of cancer-related deaths in women because most patients present with advanced stage disease at the…”
Get full text
Journal Article -
2
Metachronous double primary cancer after treatment of breast cancer
Published in Cancer research and treatment (01-01-2015)“…The pattern of double primary cancer after treatment for breast cancer is important for patient survival. We analyzed 108 cases of metachronous double primary…”
Get full text
Journal Article -
3
An Open-Label, Randomized, Parallel, Phase III Trial Evaluating the Efficacy and Safety of Polymeric Micelle-Formulated Paclitaxel Compared to Conventional Cremophor EL-Based Paclitaxel for Recurrent or Metastatic HER2-Negative Breast Cancer
Published in Cancer research and treatment (01-07-2017)“…Genexol-PM is a Cremophor EL-free formulation of low-molecular-weight, non-toxic, and biodegradable polymeric micelle-bound paclitaxel. We conducted a phase…”
Get full text
Journal Article -
4
Phase II Study of Dovitinib in Patients with Castration-Resistant Prostate Cancer (KCSG-GU11-05)
Published in Cancer research and treatment (01-10-2018)“…Fibroblast growth factor (FGF) signals are important in carcinogenesis and progression of prostate cancer. Dovitinib is an oral, pan-class inhibitor of…”
Get full text
Journal Article -
5
Concurrent Chemoradiotherapy in Locally Advanced Esophageal Cancer
Published in Radiation oncology journal (01-03-2011)“…Purpose: This study was designed to evaluate the results of local control, survival rate, prognostic factors, and failure pattern in locally advanced…”
Get full text
Journal Article -
6
Treatment Patterns and Changes in Quality of Life during First-Line Palliative Chemotherapy in Korean Patients with Advanced Gastric Cancer
Published in Cancer research and treatment (01-01-2019)“…The purpose of this study was to evaluate chemotherapy patterns and changes in quality of life (QOL) during first-line palliative chemotherapy for Korean…”
Get full text
Journal Article -
7
Metachronous double primary cancer after diagnosis of gastric cancer
Published in Cancer research and treatment (01-09-2012)“…The pattern of double primary cancers after treatment for gastric cancer is important for a patient's survival. We analyzed the clinicopathologic data of 214…”
Get full text
Journal Article -
8
Circulating Plasma Biomarkers for TSU-68, an Oral Antiangiogenic Agent, in Patients with Metastatic Breast Cancer
Published in Cancer research and treatment (01-04-2016)“…This study analyzed the role of plasma biomarkers for TSU-68 in a previous phase II trial comparing TSU-68 plus docetaxel and docetaxel alone in patients with…”
Get full text
Journal Article -
9
A Randomized Double-Blind, Double-Dummy, Multicenter Trial of Azasetron versus Ondansetron to Evaluate Efficacy and Safety in the Prevention of Delayed Nausea and Vomiting Induced by Chemotherapy
Published in Cancer research and treatment (01-01-2014)“…This study was conducted to evaluate the efficacy and safety of azasetron compared to ondansetron in the prevention of delayed chemotherapy-induced nausea and…”
Get full text
Journal Article -
10
Clinical Outcome of Rituximab-Based Therapy (RCHOP) in Diffuse Large B-Cell Lymphoma Patients with Bone Marrow Involvement
Published in Cancer research and treatment (01-06-2013)“…We investigated the clinical outcome of bone marrow (BM) involvement in patients with diffuse large B-cell lymphoma (DLBCL) who received rituximab-based…”
Get full text
Journal Article -
11
Randomized, multicenter, phase III trial of heptaplatin 1-hour infusion and 5-fluorouracil combination chemotherapy comparing with cisplatin and 5-fluorouracil combination chemotherapy in patients with advanced gastric cancer
Published in Cancer research and treatment (01-03-2009)“…Heptaplatin (Sunpla) is a cisplatin derivative. A phase IIb trial using heptaplatin resulted in a 34% response rate with mild nephrotoxicity. We conducted a…”
Get full text
Journal Article -
12
Biweekly irinotecan and cisplatin as second-line chemotherapy in pretreated patients with advanced gastric cancer: a multicenter phase II study
Published in Journal of Korean medical science (01-12-2005)“…The current phase II study was conducted to evaluate the response rate and safety of a combination regimen of biweekly irinotecan plus cisplatin in pretreated…”
Get full text
Journal Article -
13
Concurrent Chemoradiotherapy in Locally Advanced Esophageal Cancer
Published in Radiation oncology journal (30-03-2011)Get full text
Journal Article -
14
The efficacy of paclitaxel and cisplatin combination chemotherapy for the treatment of metastatic or recurrent gastric cancer: a multicenter phase II study
Published in The Korean journal of internal medicine (01-06-2005)“…Although many treatments for advanced gastric cancer have been developed, only poor treatment results have generally been obtained. We performed a prospective…”
Get full text
Journal Article -
15
담낭에 발생한 전장낭 1예
Published in The Korean journal of gastroenterology (01-01-2000)“…During the early embryonal stage of foregut development, malformations may be encountered. Foregut duplications are considered to be developed due to abnormal…”
Get full text
Journal Article -
16
잔위암 2예
Published in The Korean journal of gastroenterology (01-01-2000)“…The prevalence of gastric stump cancer ranges from 0.8% to 8.9% in other countries, but there has been a few reports in Korea. Specific factors responsible for…”
Get full text
Journal Article -
17
입원한 지역사회획득 폐렴 환자에서 요중 레지오넬라항원 검사를 통해 본 Legionella Pneumophila 감염의 비중
Published in Tuberculosis and respiratory diseases (30-04-2001)“…Background : Legionella pneumophila has been recognized as an important cause of community-acquired pneumonia(CAP) requiring hospitalization. However,…”
Get full text
Journal Article -
18
위 절제술 후 내시경으로 발견된 역행성 장중첩중
Published in Taehan Sohwagi Naesigyŏng Hakhoe chi (30-08-2008)“…역행성 장중첩증은 위장관문합술 후 드물게 나타나는 합병증이다. 특히 위 수술 후 발생하는 역행성 공장-위 중첩증은 0.1% 정도의 빈도를 보이며, 역행성 장중첩의 원인은 잘 알려져 있지 않다. 증상 발현 후 높은 사망률을 보이고 치료하지 않을 시 거의 100%의 사망률을 보이기 때문에…”
Get full text
Journal Article -
19
식도,위장관 전 위장관을 침범하고 호산구성 복수를 동반한 호산구성 위장염
Published in Taehan Sohwagi Naesigyŏng Hakhoe chi (30-05-2008)Get full text
Journal Article -
20
대장암과 연관된 허혈성 대장염 1 예
Published in Taehan Sohwagi Naesigyŏng Hakhoe chi (01-01-2002)Get full text
Journal Article